Heavy risks of weight-loss drugs
Business Standard|December 04, 2024
The health issues and social stigma associated with weight gain push obese people to try every possible solution that can help them shed unwanted kilograms. Unfortunately, many of them struggle to lose weight even with a balanced diet and plenty of exercise. This sense of failure is hard to cope with, especially in a culture that offers shame in place of support. In the face of such despair, prescription drugs seem to hold out a promise of hope.
CHINTAN GIRISH MODI
Heavy risks of weight-loss drugs

"Some financial analysts believe that the market for them could be worth as much as $200 billion globally by 2030...Ozempic and its successors look set to become one of the iconic and defining drugs of our time, on a par with the contraceptive pill and Prozac," writes Johann Hari in his new book Magic Pill: The Extraordinary Benefits and Disturbing Risks of the New Weight-Loss Drugs.

What makes the book worth reading is the author's openness to diverse perspectives. He is not a medical expert, so the information that he makes available is based on conversations with scientists, published studies, and his own experience of injecting himself with Ozempic.

Numerous Indians who were unfamiliar with the drug learned about it thanks to jewellery designer Maheep Kapoor on the Netflix show Fabulous Lives vs Bollywood Wives. She called out people who use Ozempic to lose weight quickly, leading to a shortage of the drug for diabetics. Her remarks also led to speculation around filmmaker Karan Johar's recent weight loss, who took to Instagram and stated, "Being healthy and eating well and reinventing the wheel of your nutrition! Aur Ozempic ko mile credit (And Ozempic gets the credit)?"

This story is from the December 04, 2024 edition of Business Standard.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

This story is from the December 04, 2024 edition of Business Standard.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

MORE STORIES FROM BUSINESS STANDARDView All
THE LONG ROAD TO DATA PROTECTION
Business Standard

THE LONG ROAD TO DATA PROTECTION

The DPDP Act comes with a long gestation period. What does that mean for its efficacy?

time-read
5 mins  |
January 07, 2025
Tata Punch tops '24 sales charts, ends Maruti's 40-year reign
Business Standard

Tata Punch tops '24 sales charts, ends Maruti's 40-year reign

For the first time in four decades, a non-Maruti Suzuki India car has topped the list of India's best-selling cars. In 2024, the Tata Punch, a sub-compact sport utility vehicle (SUV), became the highest-selling vehicle by delivering 202,030 units.

time-read
1 min  |
January 07, 2025
Business Standard

Isro marks milestone as cowpea seeds take root in space

Cowpea seedlings onboard PSLV-C60 POEM-4 module sprout their first leaves in space, signifying a milestone in space-based plant research, Isro said on Monday.

time-read
1 min  |
January 07, 2025
India reports 5 HMPV cases; govt says no need to panic
Business Standard

India reports 5 HMPV cases; govt says no need to panic

India on Monday reported at least five cases of Human Metapneumovirus (HMPV), which causes respiratory illness and was recently identified in China and Malaysia.

time-read
1 min  |
January 07, 2025
Business Standard

US 30-Year Bond Yield Highest Since 2023

US Treasuries slumped, lifting the yield on 30-year bonds to the highest since late 2023, as a rattled market prepares for $119 billion of fresh government debt issuance this week.

time-read
1 min  |
January 07, 2025
Business Standard

Indian Bond Index Inflows May Lag Estimates: Morgan Stanley

Indian bonds included last year in a key global benchmark will fail to draw as much money as previously estimated, according to Morgan Stanley.

time-read
1 min  |
January 07, 2025
Business Standard

Select factor fund based on conviction, risk appetite

Ajay Singh (name changed on request), a 35-year-old Noida-based lawyer, plans to invest in factor (or smart-beta) funds in 2025.

time-read
2 mins  |
January 07, 2025
Jubilant FoodWorks Hits 52-Week High
Business Standard

Jubilant FoodWorks Hits 52-Week High

Brokerages Offer Mixed Outlook After Strong Q3 Showing

time-read
2 mins  |
January 07, 2025
Business Standard

Quadrant Future Tek secures ₹131 cr from anchor investors

Quadrant Future Tek on Monday garnered ₹130.5 crore from anchor investors ahead of its initial public offering (IPO).

time-read
1 min  |
January 07, 2025
Sebi Eases Fund Settlement Norms for Dormant A/Cs
Business Standard

Sebi Eases Fund Settlement Norms for Dormant A/Cs

The Securities and Exchange Board of India (Sebi) on Monday relaxed settlement norms for brokerage accounts remaining inactive for more than 30 days.

time-read
1 min  |
January 07, 2025